|
Volumn 3, Issue 6, 2008, Pages 657-665
|
Efficacy and safety of continuous versus paused etanercept teatment in patients with moderate-to-severe psoriasis over 54 weeks: The CRYSTEL study
|
Author keywords
Etanercept; Long term effect; Open label study; Psoriasis; TNF
|
Indexed keywords
CORTICOSTEROID;
ETANERCEPT;
ETRETIN;
METHOTREXATE;
TUMOR NECROSIS FACTOR;
ABNORMAL LABORATORY RESULT;
ADULT;
ALANINE AMINOTRANSFERASE BLOOD LEVEL;
ALOPECIA;
ARTICLE;
ASTHENIA;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEMYELINATING DISEASE;
DISEASE EXACERBATION;
DISEASE SEVERITY;
DOSAGE SCHEDULE COMPARISON;
DOSE RESPONSE;
DRUG DOSE REGIMEN;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
FEMALE;
HEADACHE;
HUMAN;
INFECTION;
LONG TERM CARE;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
MULTIPLE CYCLE TREATMENT;
NONHODGKIN LYMPHOMA;
OPEN STUDY;
PATIENT SATISFACTION;
PHOTOTHERAPY;
PRIORITY JOURNAL;
PRURITUS;
PSORIASIS SEVERITY INDEX;
PSORIASIS VULGARIS;
RANDOMIZED CONTROLLED TRIAL;
RELAPSE;
SIDE EFFECT;
SKIN CANCER;
SYSTEMIC THERAPY;
TOPICAL TREATMENT;
TREATMENT DURATION;
TREATMENT RESPONSE;
TUBERCULOSIS;
UPPER RESPIRATORY TRACT INFECTION;
|
EID: 67651170405
PISSN: 17469872
EISSN: None
Source Type: Journal
DOI: 10.1586/17469872.3.6.657 Document Type: Article |
Times cited : (39)
|
References (8)
|